Chad Messer
Stock Analyst at Lake Street
(1.24)
# 3,744
Out of 5,105 analysts
29
Total ratings
41.38%
Success rate
-12.26%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Chad Messer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OSTX OS Therapies | Maintains: Buy | $18 → $17 | $1.81 | +839.23% | 2 | Nov 18, 2025 | |
| GNLX Genelux | Initiates: Buy | $16 | $4.33 | +269.94% | 1 | Oct 21, 2025 | |
| MNPR Monopar Therapeutics | Initiates: Buy | $106 | $74.61 | +42.08% | 1 | Sep 23, 2025 | |
| BOLT Bolt Biotherapeutics | Maintains: Buy | $4 → $75 | $5.41 | +1,286.32% | 2 | Aug 15, 2025 | |
| ONCY Oncolytics Biotech | Initiates: Buy | $7 | $0.99 | +604.86% | 1 | Aug 13, 2025 | |
| COYA Coya Therapeutics | Initiates: Buy | $16 | $6.18 | +158.90% | 1 | Jul 9, 2025 | |
| LTRN Lantern Pharma | Initiates: Buy | $25 | $3.60 | +594.44% | 1 | Apr 2, 2025 | |
| IMNM Immunome | Initiates: Buy | $23 | $19.57 | +17.53% | 1 | Apr 2, 2025 | |
| ESPR Esperion Therapeutics | Maintains: Strong Buy | $134 → $114 | $3.85 | +2,861.04% | 3 | Aug 3, 2021 | |
| CELC Celcuity | Initiates: Buy | $50 | $105.25 | -52.49% | 1 | Jul 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $48 | $63.35 | -24.23% | 2 | Jul 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $30 | $40.88 | -26.61% | 3 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $71.83 | -30.39% | 1 | Jun 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $29 | $11.49 | +152.39% | 2 | May 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $2.17 | +360.83% | 1 | Apr 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $95 → $86 | $80.82 | +6.41% | 2 | Mar 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $44 | $19.07 | +130.73% | 2 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $182 → $166 | $21.53 | +671.02% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $18 | $1.66 | +984.34% | 1 | May 5, 2020 |
OS Therapies
Nov 18, 2025
Maintains: Buy
Price Target: $18 → $17
Current: $1.81
Upside: +839.23%
Genelux
Oct 21, 2025
Initiates: Buy
Price Target: $16
Current: $4.33
Upside: +269.94%
Monopar Therapeutics
Sep 23, 2025
Initiates: Buy
Price Target: $106
Current: $74.61
Upside: +42.08%
Bolt Biotherapeutics
Aug 15, 2025
Maintains: Buy
Price Target: $4 → $75
Current: $5.41
Upside: +1,286.32%
Oncolytics Biotech
Aug 13, 2025
Initiates: Buy
Price Target: $7
Current: $0.99
Upside: +604.86%
Coya Therapeutics
Jul 9, 2025
Initiates: Buy
Price Target: $16
Current: $6.18
Upside: +158.90%
Lantern Pharma
Apr 2, 2025
Initiates: Buy
Price Target: $25
Current: $3.60
Upside: +594.44%
Immunome
Apr 2, 2025
Initiates: Buy
Price Target: $23
Current: $19.57
Upside: +17.53%
Esperion Therapeutics
Aug 3, 2021
Maintains: Strong Buy
Price Target: $134 → $114
Current: $3.85
Upside: +2,861.04%
Celcuity
Jul 27, 2021
Initiates: Buy
Price Target: $50
Current: $105.25
Upside: -52.49%
Jul 19, 2021
Maintains: Buy
Price Target: $33 → $48
Current: $63.35
Upside: -24.23%
Jun 28, 2021
Maintains: Buy
Price Target: $33 → $30
Current: $40.88
Upside: -26.61%
Jun 17, 2021
Initiates: Buy
Price Target: $50
Current: $71.83
Upside: -30.39%
May 14, 2021
Maintains: Buy
Price Target: $31 → $29
Current: $11.49
Upside: +152.39%
Apr 5, 2021
Initiates: Buy
Price Target: $10
Current: $2.17
Upside: +360.83%
Mar 23, 2021
Maintains: Buy
Price Target: $95 → $86
Current: $80.82
Upside: +6.41%
Jan 8, 2021
Maintains: Buy
Price Target: $35 → $44
Current: $19.07
Upside: +130.73%
Jan 8, 2021
Maintains: Buy
Price Target: $182 → $166
Current: $21.53
Upside: +671.02%
May 5, 2020
Maintains: Buy
Price Target: $15 → $18
Current: $1.66
Upside: +984.34%